437
Views
5
CrossRef citations to date
0
Altmetric
Review

A patent review of berberine and its derivatives with various pharmacological activities (2016–2020)

, , , &
Pages 211-223 | Received 18 May 2021, Accepted 25 Aug 2021, Published online: 17 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tran Thi Thu Hien, Vinh Le Ba, Nguyen Quoc Huy, Nguyen Phuong Thao, Seo Young Yang & Le Thi Kim Van. (2023) Cytotoxic effects of aporphine alkaloids from the stems and leaves of Stephania dielsiana Y.C.Wu. Natural Product Research 0:0, pages 1-10.
Read now

Articles from other publishers (4)

Ying Li & Xizhen Ge. (2023) Role of Berberine as a Potential Efflux Pump Inhibitor against MdfA from Escherichia coli: In Vitro and In Silico Studies . Microbiology Spectrum 11:2.
Crossref
Mikhail V. Khvostov, Elizaveta D. Gladkova, Sergey A. Borisov, Marina S. Fedotova, Nataliya A. Zhukova, Mariya K. Marenina, Yuliya V. Meshkova, Olga A. Luzina, Tatiana G. Tolstikova & Nariman F. Salakhutdinov. (2022) Study of Hypoglycemic Activity of Novel 9-N-alkyltetrahydroberberine Derivatives. International Journal of Molecular Sciences 23:22, pages 14186.
Crossref
Hongjuan Zhou, Wenzhao Shi, Jinshu Liu, Guoxin Su, Shanshan Cui, Manyan Zhang & Susong Li. (2022) Enhanced developing property of latent fingerprint based on inclusion complex of β-cyclodextrin with natural berberine extracted from Coptis chinensis. Chemical Papers 76:8, pages 4893-4905.
Crossref
Jing Guo, Hongdong Chen, Xueqin Zhang, Wenjiao Lou, Pingna Zhang, Yuheng Qiu, Chao Zhang, Yaoxian Wang & Wei Jing Liu. (2021) The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxidative Medicine and Cellular Longevity 2021, pages 1-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.